Related Experiment Videos
HLA complex and familial malignant melanoma
International Journal of Cancer
|June 15, 1982
Summary
Familial malignant melanoma (FMM) may be linked to the Human Leukocyte Antigen (HLA) complex. This study suggests two types of FMM exist, one linked to HLA and another not, potentially involving complementary genetic factors.
Area of Science:
- Immunogenetics
- Dermatology
- Cancer Genetics
Background:
- Familial malignant melanoma (FMM) suggests a genetic predisposition.
- The Human Leukocyte Antigen (HLA) complex plays a crucial role in immune response and has been implicated in various cancers.
Purpose of the Study:
- To investigate the potential linkage between familial malignant melanoma and the HLA complex.
- To determine if specific HLA antigens segregate with FMM within affected families.
Main Methods:
- HLA-A, -B, and -C typing was performed on six families with FMM.
- Segregation analysis was conducted to assess HLA-FMM linkage.
Main Results:
- The HLA-B12 antigen was identified in five of the six FMM families.
- Linkage between HLA and FMM was observed in two out of three analyzable families.
- Findings suggest two types of FMM: one segregating with the HLA complex (more frequent) and one not (less frequent).
Conclusions:
- A significant portion of FMM cases may be associated with the HLA complex, suggesting a genetic link.
- The results support a hypothesis of two complementary genetic factors, one within the HLA complex, contributing to FMM development with dominant inheritance and high penetrance.